Brief: Xilio Therapeutics Q1 Net Income USD -17.203 Million
14/05/2024 12:30
May 14 (Reuters) - Xilio Therapeutics Q1 basic EPS USD -0.62. * Q1 operating expenses USD 17.487 million * Q1 income from operations USD -17.487 million
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla